Testosterone Increases Fracture Risk in Hypogonadal Men?
Though testosterone treatment improves bone strength and structure, a large study on older hypogonadal men showed a high risk for fracture with the treatment.
Stay updated with breaking news from Peterj Snyder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Though testosterone treatment improves bone strength and structure, a large study on older hypogonadal men showed a high risk for fracture with the treatment.
An unexpected finding of the TRAVERSE trial is that testosterone gel treatment did not reduce the risk for clinical fractures, and, in fact, increased the risk A substudy finds that testosterone treatment in men with hypogonadism did not reduce the risk of clinical fractures.
Findings show no reduction in clinical fracture among middle-aged, older men with hypogonadism.
Testosterone treatment does not result in a lower incidence of clinical fractures among middle-aged and older men with hypogonadism.
Fracture occurrences were numerically higher among men who received testosterone than placebo across a subtrial of the phase 4 TRAVERSE trial.